ONDANSETRON HYDROCH

The Defense Logistics Agency awarded Cardinal Health, Inc. a delivery order under contract SPE2DX25D8022 for the procurement of two units of Ondansetron Hydrochloride, identified by NSN 6505015818923 and manufacturer part NDC00378-7732-93, at a total contract value of $7.34. The award, issued on July 16, 2026, reflects a single-line item, fixed-quantity purchase with no variance permitted in quantity, indicating a minimal-risk, straightforward supply transaction. Delivery is required to be made FOB destination to Electric Boat Corporation in North Stonington, Connecticut, with the contractor responsible for all shipping costs and transportation risk. Tracking is mandated via NSN, PR number 7017530542, and CAGE codes 00E55, 3KJG9, and 8APG0, with shipping instructions requiring traceable methods and explicitly prohibiting parcel post. Inspection and acceptance occur at the delivery location, and funding is allocated using RANK code 01-83980001213, DIC A4A, DIST M9L, and FC 68, though formal accounting identifiers such as TAS or AAC are not specified. The contract lacks explicit FAR or DFARS clauses, attachment lists, special requirements, or evaluation factors, suggesting it was processed as a low-value commercial item under typical DLA streamlined acquisition practices, likely on a Lowest Price Technically Acceptable basis. Packaging, labeling, and quality standards are not detailed, though compliance with military pharmaceutical procurement norms is implied by the use of NSN and FDA-associated product identifiers. No security clearances, key personnel requirements, options, or organizational conflict of interest provisions are included, and no representation or certification data beyond the awardee’s CAGE code is available. Payment is handled by the contractor under FOB Destination terms, and the invoice method remains unspecified.